Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells

類似資料

• Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations
  著者:: Rittler, Dominika, 等
  出版事項: (2020)
• The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb
  著者:: Rittler, Dominika, 等
  出版事項: (2019)
• Allosteric and ATP-Competitive MEK-Inhibition in a Novel Spitzoid Melanoma Model with a RAF- and Phosphorylation-Independent Mutation
  著者:: Hegedüs, Luca, 等
  出版事項: (2021)
• Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression
  著者:: Molnár, Eszter, 等
  出版事項: (2019)
• Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells
  著者:: Garay, Tamás, 等
  出版事項: (2015)